FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2963929878> ?p ?o ?g. }

• W2963929878 endingPage "e1359" @default.
• W2963929878 startingPage "e1351" @default.
• W2963929878 abstract "Abstract Background The primary objective was to evaluate the rates of older patients with colorectal cancer (CRC) who were eligible for a clinical trial, invited to participate, and, ultimately, included. The secondary objective was to assess the reasons for ineligibility, noninvitation, and noninclusion and factors associated. Materials and Methods The Sujets AGés dans les Essais Cliniques (SAGE; Older Subjects in Clinical Trials) multicenter prospective cohort was established in seven centers (10 departments of medical oncology, digestive oncology, and digestive surgery) between 2012 and 2016. All patients with CRC aged 65 or older were studied. The endpoints were clinical trial availability, patient's eligibility, invitation, and enrollment in a trial. Results We included 577 older patients (mean age ± SD: 75.6 ± 7 years; males: 56%; metastasis: 41%). Thirty-seven trials were ongoing (one trial for older patients). Of the 474 patients with at least one available trial for their cancer stage and site, 127 (27%) were eligible; 84 of these 127 (66%) were invited to participate, and 70 of these 84 (83%) were included. In a multivariate analysis, noninvitation was found to be associated with older age (p = .016): adjusted relative risk (95% confidence interval), 0.14 (0.02–0.60) for ≥80 vs. 65–69; 0.54 (0.18-1.04) for 75–79 vs. 65–69; 0.47 (0.17-0.93) for 70–74 vs. 65–69. Conclusion Three-quarters of older patients with CRC were ineligible for a clinical trial. One-third of the eligible patients were not invited to participate in a trial, and 17% of invited patients were not included. Few trials are reserved for older patients. Patients aged 80 or older were significantly less likely to be eligible for a trial and invited to participate. Clinical trial identification number: NCT01754636. Implications for Practice The results of this study suggest that barriers to participation of older patients in clinical trials are particularly marked at age 80 years or older. Secondly, the results emphasize the need for trials for older patients. Thirdly, there is also a need for more pragmatic “real-world” trials, rather than solely randomized trials performed in idealized settings with strictly selected patients. Large prospective observational cohorts with a precise follow-up of toxicity, functional decline, and quality of life may constitute one way of generating more data on the risk-benefit ratio for cancer treatments in older patients." @default.
• W2963929878 created "2019-07-30" @default.
• W2963929878 creator A5003745000 @default.
• W2963929878 creator A5007712227 @default.
• W2963929878 creator A5007913434 @default.
• W2963929878 creator A5012882107 @default.
• W2963929878 creator A5020893157 @default.
• W2963929878 creator A5030689032 @default.
• W2963929878 creator A5036768799 @default.
• W2963929878 creator A5040985815 @default.
• W2963929878 creator A5047206524 @default.
• W2963929878 creator A5048135259 @default.
• W2963929878 creator A5070237613 @default.
• W2963929878 creator A5074346281 @default.
• W2963929878 creator A5076325206 @default.
• W2963929878 creator A5083396561 @default.
• W2963929878 creator A5090375155 @default.
• W2963929878 date "2019-07-19" @default.
• W2963929878 modified "2023-10-08" @default.
• W2963929878 title "Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey" @default.
• W2963929878 cites W1931781407 @default.
• W2963929878 cites W1964543752 @default.
• W2963929878 cites W1983117789 @default.
• W2963929878 cites W2022571127 @default.
• W2963929878 cites W2037668591 @default.
• W2963929878 cites W2043990618 @default.
• W2963929878 cites W2074048861 @default.
• W2963929878 cites W2075831933 @default.
• W2963929878 cites W2085165820 @default.
• W2963929878 cites W2101322472 @default.
• W2963929878 cites W2114509795 @default.
• W2963929878 cites W2115598517 @default.
• W2963929878 cites W2116063553 @default.
• W2963929878 cites W2120307638 @default.
• W2963929878 cites W2131423565 @default.
• W2963929878 cites W2148623946 @default.
• W2963929878 cites W2155750728 @default.
• W2963929878 cites W2159296014 @default.
• W2963929878 cites W2281930375 @default.
• W2963929878 cites W2460621480 @default.
• W2963929878 cites W2508710421 @default.
• W2963929878 cites W2514781473 @default.
• W2963929878 cites W2521887788 @default.
• W2963929878 cites W2562830036 @default.
• W2963929878 cites W2749103124 @default.
• W2963929878 cites W2792883292 @default.
• W2963929878 cites W2801520211 @default.
• W2963929878 cites W3022423927 @default.
• W2963929878 doi "https://doi.org/10.1634/theoncologist.2019-0166" @default.
• W2963929878 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6975930" @default.
• W2963929878 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31324663" @default.
• W2963929878 hasPublicationYear "2019" @default.
• W2963929878 type Work @default.
• W2963929878 sameAs 2963929878 @default.
• W2963929878 citedByCount "38" @default.
• W2963929878 countsByYear W29639298782019 @default.
• W2963929878 countsByYear W29639298782020 @default.
• W2963929878 countsByYear W29639298782021 @default.
• W2963929878 countsByYear W29639298782022 @default.
• W2963929878 countsByYear W29639298782023 @default.
• W2963929878 crossrefType "journal-article" @default.
• W2963929878 hasAuthorship W2963929878A5003745000 @default.
• W2963929878 hasAuthorship W2963929878A5007712227 @default.
• W2963929878 hasAuthorship W2963929878A5007913434 @default.
• W2963929878 hasAuthorship W2963929878A5012882107 @default.
• W2963929878 hasAuthorship W2963929878A5020893157 @default.
• W2963929878 hasAuthorship W2963929878A5030689032 @default.
• W2963929878 hasAuthorship W2963929878A5036768799 @default.
• W2963929878 hasAuthorship W2963929878A5040985815 @default.
• W2963929878 hasAuthorship W2963929878A5047206524 @default.
• W2963929878 hasAuthorship W2963929878A5048135259 @default.
• W2963929878 hasAuthorship W2963929878A5070237613 @default.
• W2963929878 hasAuthorship W2963929878A5074346281 @default.
• W2963929878 hasAuthorship W2963929878A5076325206 @default.
• W2963929878 hasAuthorship W2963929878A5083396561 @default.
• W2963929878 hasAuthorship W2963929878A5090375155 @default.
• W2963929878 hasBestOaLocation W29639298781 @default.
• W2963929878 hasConcept C121608353 @default.
• W2963929878 hasConcept C126322002 @default.
• W2963929878 hasConcept C188816634 @default.
• W2963929878 hasConcept C2777319248 @default.
• W2963929878 hasConcept C44249647 @default.
• W2963929878 hasConcept C526805850 @default.
• W2963929878 hasConcept C535046627 @default.
• W2963929878 hasConcept C71924100 @default.
• W2963929878 hasConcept C72563966 @default.
• W2963929878 hasConceptScore W2963929878C121608353 @default.
• W2963929878 hasConceptScore W2963929878C126322002 @default.
• W2963929878 hasConceptScore W2963929878C188816634 @default.
• W2963929878 hasConceptScore W2963929878C2777319248 @default.
• W2963929878 hasConceptScore W2963929878C44249647 @default.
• W2963929878 hasConceptScore W2963929878C526805850 @default.
• W2963929878 hasConceptScore W2963929878C535046627 @default.
• W2963929878 hasConceptScore W2963929878C71924100 @default.
• W2963929878 hasConceptScore W2963929878C72563966 @default.
• W2963929878 hasFunder F4320321445 @default.
• W2963929878 hasIssue "12" @default.
• W2963929878 hasLocation W29639298781 @default.

• next